Streetbeat News

EQBBF

EQT AB

https://www.eqtgroup.com/

CEO

Christian Sinding

Industry

Securities and Commodity Exchanges

Open

26.00

Mkt cap

33B

Volume

500

High

26.22

P/E Ratio

97.11

52-wk high

36.15

Low

26.00

Div yield

0.01

52-wk low

20.44

Blackstone Inc. (NYSE:BX) is considering selling its Japanese consumer healthcare firm Alinamin Pharmaceutical Co., which could be valued at approximately ¥300 billion ($1.9 billion). The sale is attracting interest from CVC Capital Partners, EQT AB (OTC:EQBBF), and MBK Partners. Other possibilities include an initial public offering. Blackstone acquired Alinamin from Takeda Pharmaceutical Company Limited (NYSE:TAK) in 2021 for ¥242 billion.

Portfolio Pulse from Akanksha Bakshi

June 03, 2024 | 3:28 pm

Perficient, Inc. (NASDAQ:PRFT) shares surged in premarket trading after announcing an acquisition by BPEA Private Equity Fund VIII, part of EQT AB (OTC:EQBBF), for about $3.0 billion, or $76.00 per share in cash. This price is a significant premium over recent closing and average prices. The deal is expected to close by end-2024. Additionally, Perficient reported a 7% year-over-year decline in Q1 FY24 revenue to $215.3 million and a 26% drop in adjusted EPS to $0.77. Following the acquisition news, Perficient withdrew its 2024 financial guidance.

Portfolio Pulse from Lekha Gupta

May 06, 2024 | 11:05 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.